EGF-induced Src activation enhances the localization of pseudopodium-enriched atypical kinase 1 (PEAK1), which was reported to be markedly upregulated in 81% of patients with CRC, to the actin cytoskeleton and focal adhesion. This evidence concerns the gene PEAK1 and colorectal carcinoma.